Discovery Chemistry, Pfizer Global Research and Development, Sandwich, United Kingdom.
Bioorg Med Chem Lett. 2009 Oct 15;19(20):5893-7. doi: 10.1016/j.bmcl.2009.08.066. Epub 2009 Aug 21.
A second wave of potential SSRIs with high ease of synthetic accessibility were designed based on the reported selective serotonin re-uptake inhibitor litoxetine and our own previous work in this area. Preparation and subsequent optimisation yielded a range of potent and highly selective SSRIs.
基于已报道的选择性 5-羟色胺再摄取抑制剂利托西汀和我们在该领域的先前工作,设计了第二批具有高合成可及性的潜在 SSRIs。制备和随后的优化得到了一系列有效且高度选择性的 SSRIs。